(EMAILWIRE.COM, August 03, 2018 ) “Consumables are expected to grow at the highest CAGR during the forecast period.”

Based on product, the cell culture market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to register the highest CAGR during the forecast period. The repeated purchase of consumables for various cell culture applications is the major factor supporting the growth of the consumables segment during the forecast period.

Browse 258 market data Tables and 36 Figures spread through 247 Pages and in-depth TOC on "Cell Culture Market"
https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

“Pharmaceutical and biotechnology companies are expected to dominate the market during the forecast period.”

Based on end user, the cell culture market is segmented into pharmaceutical and biotechnology companies and research institutes. The pharmaceutical and biotechnology companies segment accounted for the largest market share in 2017 and is projected to register the highest CAGR during the forecast period. The growing use of single-use technologies, increasing number of regulatory approvals for cell culture-based vaccines, and presence of a large number of pharmaceutical players in this market are driving the cell culture market for this end-user segment.

“Asia to witness the highest growth during the forecast period.”

In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in the Asian market is attributed to factors such as favorable regulatory guidelines, lower manufacturing costs, growing presence of market players in emerging economies, and favorable government investments in the life sciences sector.

The primary interviews conducted for this report can be categorized as follows:

• By Company Type: Tier 1 – 36%; Tier 2 - 46%; Tier 3 - 18%.
• By Designation: C-level- 29%; D-level- 43%; Others- 28%.
• By Region: North America-39%; Europe-29%; Asia -20%; Rest of the World- 12%

List of companies profiled in the report

• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• GE Healthcare (US)
• Lonza (Switzerland)
• Becton, Dickinson and Company (US)
• Corning Incorporated (US)
• Eppendorf AG (Germany)
• HiMedia Laboratories (India)
• Sartorius AG (Germany)

Press Release: https://www.marketsandmarkets.com/PressReleases/cell-culture.asp

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.